Neurones

NEURONES: Organic growth up 5.1% in 3rd quarter 2025

05 Nov 2025 11:40:00 By Nasdaq GlobeNewswire

NEURONES: Declaration of transactions on treasury shares (October 13 to 17, 2025)

21 Oct 2025 12:01:43 By Nasdaq GlobeNewswire

Neurones: 6.3% net profit in 1st half 2025

10 Sep 2025 11:40:00 By Nasdaq GlobeNewswire

NEURONES: Organic growth up 5.3% in 2nd quarter 2025

06 Aug 2025 11:40:00 By Nasdaq GlobeNewswire

NEURONES: 3.9% increase in organic growth in the 1st quarter of 2025

07 May 2025 11:40:00 By Nasdaq GlobeNewswire

Neurones: Net profit up 7.8% in 2024

05 Mar 2025 11:40:00 By Nasdaq GlobeNewswire

NEURONES: 8.6% organic growth in 2024

12 Feb 2025 11:40:00 By Nasdaq GlobeNewswire

Neurones: Organic growth up 10.5% in 3rd quarter 2024

06 Nov 2024 11:40:00 By Nasdaq GlobeNewswire

Neurones: 7.3% net profit in 1st half 2024

11 Sep 2024 12:07:26 By Nasdaq GlobeNewswire

NEURONES: Growth up 9.1% in 1st half 2024

07 Aug 2024 11:40:00 By Nasdaq GlobeNewswire

NEURONES: organic growth up 8.6% in 1st quarter 2024

15 May 2024 11:40:00 By Nasdaq GlobeNewswire

NEURONES: Net profit (group share) up 11.5% in 2023

06 Mar 2024 11:40:00 By Nasdaq GlobeNewswire

NEURONES: 11.1% organic growth in 2023

07 Feb 2024 11:40:00 By Nasdaq GlobeNewswire

NEURONES: Organic growth up 12.3% over the first nine months of the year

08 Nov 2023 11:40:00 By Nasdaq GlobeNewswire

NEURONES: 8.1% net profit in 1st half 2023

06 Sep 2023 11:40:00 By Nasdaq GlobeNewswire

NEURONES: Organic growth up 12.9% in 1st half 2023

02 Aug 2023 11:40:00 By Nasdaq GlobeNewswire

NEURONES: Organic growth up 15.1% in 1st quarter 2023

10 May 2023 11:40:00 By Nasdaq GlobeNewswire

NEURONES: 7.8% net profit in 2022

08 Mar 2023 11:40:00 By Nasdaq GlobeNewswire

NEURONES: 14.2% organic growth in 2022

08 Feb 2023 11:40:00 By Nasdaq GlobeNewswire

NEURONES: Organic growth up 14.7% in 3rd quarter 2022

09 Nov 2022 11:40:00 By Nasdaq GlobeNewswire